Paying Attention to Attention-Deficit/Hyperactivity Disorder Medications and Cardiovascular Risk

JAMA Netw Open. 2022 Nov 1;5(11):e2243606. doi: 10.1001/jamanetworkopen.2022.43606.
No abstract available

Publication types

  • Comment

MeSH terms

  • Attention Deficit Disorder with Hyperactivity* / drug therapy
  • Cardiovascular Diseases* / epidemiology
  • Heart Disease Risk Factors
  • Humans
  • Risk Factors